Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Tax Provisions (2020 - 2026)

Updated

Rallybio's Tax Provisions was $80,000 in Q3 2026, down 94.0% from the prior quarter.

Analysis

Rallybio (RLYB) Tax Provisions (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rallybio's Tax Provisions was $1.4 million through Sep 30, 2026; for FY2020, it was -$15,000.

  • The Q3 2026 figure marks the lowest quarterly Tax Provisions since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -176.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 609.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -842.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 634.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 134.00 Mn
10 Rallybio 84.05 Mn -201.02 Mn - 80,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 80,000.00
Jun 30, 2026 1.32 Mn
Dec 31, 2020 1,000.00
API Access

Rallybio Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RLYB&period=max&api_key=YOUR_API_KEY